Viatris Inc.

US$19.91As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:VTRSHealthcare
Country USA
PE (Fwd) •••
TSR 10Y CAGR (3.73%)
Div yield 2.41%
ROE (4.21%)
Drug Manufacturers (Specialty & Generic)
Beta (5Y) 0.87
PE TTM —
TSR TTM 98.99%
Mkt cap US$22.83B
ROIC 6.55%
SE Grade™
Value
Quality
Moat
Consensus
Reference
$24
21.62%
(23.34%)
Hold 0|2|4|2|9
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.27
0.29
0.30
0.34
8.58%
21.72%
15.55%
27.15%
Revenue$B
1.847
1.932
1.922
1.968
7.66%
12.51%
6.39%
11.49%
Peers (US$22.83B)
Cap (US$)
PE
32.26B
13.40x
23.94B
21.18x
Capital
TTM
5Y
10Y
Leveragex
0.322
(0.460)
(0.453)
EBIT/Intx
0.608
0.342
0.280
Own earn%
18.67
15.67
22.76
Sh yield%
47.00
53.65
54.34
Owners
Insiders/Inst%
12.80
40.85
Short interest%
2.04
SBC / revenue%
1.78
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
12
Op margin range%
7–19
$1 testx
—
Incr. ROIC%
11